Click to zoom
Product Description
NOXALK 150 mg capsules (Ceritinib) are an oral, targeted kinase inhibitor manufactured by Natco Pharma. They are primarily used to treat adults with advanced or metastatic ALK-positive non-small cell lung cancer (NSCLC) who have progressed on or cannot tolerate crizotinib.
liketo.usa,uk,china,southkorea,russia,japan,singapore
Composition
Strength 150 mg
Pack Size 90 capsules
Brand NOXALK
Company Natco
Usage Lung cancer, NSCLC
Shelf Life 24 months
Packaging Size 90 capsules
Brand Name Noxalk
Manufacturer Natco
Packaging Type Bottle
Product Form Capsules
Composition Ceritinib Capsules IP
Minimum order quantity: 50 Box
Shipping Information
We offer reliable delivery across India and international markets. Domestic orders are typically delivered within 5-7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity.
200 mg canditRAL 200 Itraconazole Capsules
On Request
200 mg ITRASPOROX - 200 Itraconazole Capsules
On Request
801 mg Pirfenex Pirfenidone IP Tablets
On Request
400 mg Pirfeheal 400 Pirfenidone IP Tablets
On Request
200 mg Fibrodone Pirfenidone I.P. Tablets
On Request
100 mg PEMNAT 100 Pemetrexed for Injection
On Request
500 mg PEMAXAM-500 Pemetrexed IP Injection
On Request
150 mg nindanib 150 Nintedanib soft gelatin capsules
On Request